CD99 - Revision history

Michael: /* Positive */

2015-10-15T12:40:05Z

Positive

← Older revision		Revision as of 12:40, 15 October 2015
Line 7:		Line 7:
	*[[Angiomatoid fibrous histiocytoma]].		*[[Angiomatoid fibrous histiocytoma]].
	*[[Desmoplastic small round cell tumour]].		*[[Desmoplastic small round cell tumour]].

			===Weak/cytoplasmic staining===
			*[[Synovial sarcoma]].
			*[[Rhabdomyosarcoma]].
			*[[Rhabdoid tumour]].

	===Others===		===Others===

Michael at 12:38, 15 October 2015

2015-10-15T12:38:58Z

← Older revision		Revision as of 12:38, 15 October 2015
Line 4:		Line 4:
	===Membrane staining===		===Membrane staining===
	*[[Ewing sarcoma]] - diffuse (plasma membrane) staining.		*[[Ewing sarcoma]] - diffuse (plasma membrane) staining.
	*[[Lymphoblastic lymphoma/leukemia]].		*Lymphoblastic lymphoma/leukemia.
	*[[Angiomatoid fibrous histiocytoma]].		*[[Angiomatoid fibrous histiocytoma]].
	*[[Desmoplastic small round cell tumour]].		*[[Desmoplastic small round cell tumour]].

Michael at 12:38, 15 October 2015

2015-10-15T12:38:46Z

← Older revision		Revision as of 12:38, 15 October 2015
Line 2:		Line 2:

	==Positive==		==Positive==
	*[[Ewing sarcoma]] - diffuse plasma membrane staining.		===Membrane staining===
			*[[Ewing sarcoma]] - diffuse (plasma membrane) staining.
			*[[Lymphoblastic lymphoma/leukemia]].
			*[[Angiomatoid fibrous histiocytoma]].
			*[[Desmoplastic small round cell tumour]].

			===Others===
	*[[Malignant melanoma]] (9 of 10 cases<ref name=pmid11789717>{{Cite journal \| last1 = Monteagudo \| first1 = C. \| last2 = Calduch \| first2 = L. \| last3 = Navarro \| first3 = S. \| last4 = Joan-Figueroa \| first4 = A. \| last5 = Llombart-Bosch \| first5 = A. \| title = CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. \| journal = Am J Clin Pathol \| volume = 117 \| issue = 1 \| pages = 126-31 \| month = Jan \| year = 2002 \| doi = 10.1309/2EXB-70CW-3U6P-VQ6H \| PMID = 11789717 }}</ref>).		*[[Malignant melanoma]] (9 of 10 cases<ref name=pmid11789717>{{Cite journal \| last1 = Monteagudo \| first1 = C. \| last2 = Calduch \| first2 = L. \| last3 = Navarro \| first3 = S. \| last4 = Joan-Figueroa \| first4 = A. \| last5 = Llombart-Bosch \| first5 = A. \| title = CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. \| journal = Am J Clin Pathol \| volume = 117 \| issue = 1 \| pages = 126-31 \| month = Jan \| year = 2002 \| doi = 10.1309/2EXB-70CW-3U6P-VQ6H \| PMID = 11789717 }}</ref>).
	*[[Atypical fibroxanthoma]] (19 of 26 cases<ref name=pmid11789717/>).		*[[Atypical fibroxanthoma]] (19 of 26 cases<ref name=pmid11789717/>).

Michael at 12:36, 15 October 2015

2015-10-15T12:36:58Z

← Older revision		Revision as of 12:36, 15 October 2015
Line 1:		Line 1:
	'''CD99''' is a commonly available [[immunostain]] with various uses.		'''CD99''' is a commonly available [[immunostain]] with various uses. It stains a lot of different tumour and has been described by one soft tissue pathologist as ''slutty''.

	==Positive==		==Positive==
			*[[Ewing sarcoma]] - diffuse plasma membrane staining.
	*[[Malignant melanoma]] (9 of 10 cases<ref name=pmid11789717>{{Cite journal \| last1 = Monteagudo \| first1 = C. \| last2 = Calduch \| first2 = L. \| last3 = Navarro \| first3 = S. \| last4 = Joan-Figueroa \| first4 = A. \| last5 = Llombart-Bosch \| first5 = A. \| title = CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. \| journal = Am J Clin Pathol \| volume = 117 \| issue = 1 \| pages = 126-31 \| month = Jan \| year = 2002 \| doi = 10.1309/2EXB-70CW-3U6P-VQ6H \| PMID = 11789717 }}</ref>).		*[[Malignant melanoma]] (9 of 10 cases<ref name=pmid11789717>{{Cite journal \| last1 = Monteagudo \| first1 = C. \| last2 = Calduch \| first2 = L. \| last3 = Navarro \| first3 = S. \| last4 = Joan-Figueroa \| first4 = A. \| last5 = Llombart-Bosch \| first5 = A. \| title = CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. \| journal = Am J Clin Pathol \| volume = 117 \| issue = 1 \| pages = 126-31 \| month = Jan \| year = 2002 \| doi = 10.1309/2EXB-70CW-3U6P-VQ6H \| PMID = 11789717 }}</ref>).
	*[[Atypical fibroxanthoma]] (19 of 26 cases<ref name=pmid11789717/>).		*[[Atypical fibroxanthoma]] (19 of 26 cases<ref name=pmid11789717/>).

			==Negative==
			*[[Squamous cell carcinoma]].<ref name=pmid11789717/>
			*[[Undifferentiated small round cell sarcoma with t(4;19)]] (CIC-DUX sarcoma) - negative or weak positive.

	==See also==		==See also==

Michael at 12:33, 15 October 2015

2015-10-15T12:33:36Z

← Older revision		Revision as of 12:33, 15 October 2015
Line 3:		Line 3:
	==Positive==		==Positive==
	*[[Malignant melanoma]] (9 of 10 cases<ref name=pmid11789717>{{Cite journal \| last1 = Monteagudo \| first1 = C. \| last2 = Calduch \| first2 = L. \| last3 = Navarro \| first3 = S. \| last4 = Joan-Figueroa \| first4 = A. \| last5 = Llombart-Bosch \| first5 = A. \| title = CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. \| journal = Am J Clin Pathol \| volume = 117 \| issue = 1 \| pages = 126-31 \| month = Jan \| year = 2002 \| doi = 10.1309/2EXB-70CW-3U6P-VQ6H \| PMID = 11789717 }}</ref>).		*[[Malignant melanoma]] (9 of 10 cases<ref name=pmid11789717>{{Cite journal \| last1 = Monteagudo \| first1 = C. \| last2 = Calduch \| first2 = L. \| last3 = Navarro \| first3 = S. \| last4 = Joan-Figueroa \| first4 = A. \| last5 = Llombart-Bosch \| first5 = A. \| title = CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. \| journal = Am J Clin Pathol \| volume = 117 \| issue = 1 \| pages = 126-31 \| month = Jan \| year = 2002 \| doi = 10.1309/2EXB-70CW-3U6P-VQ6H \| PMID = 11789717 }}</ref>).
	*[[Atypical fibroxanthoma]] (19 of 26 cases<ref name=pmid11789717>).		*[[Atypical fibroxanthoma]] (19 of 26 cases<ref name=pmid11789717/>).


	==See also==		==See also==

Michael: create

2015-10-15T12:33:18Z

create

New page

'''CD99''' is a commonly available [[immunostain]] with various uses.

==Positive==
*[[Malignant melanoma]] (9 of 10 cases<ref name=pmid11789717>{{Cite journal | last1 = Monteagudo | first1 = C. | last2 = Calduch | first2 = L. | last3 = Navarro | first3 = S. | last4 = Joan-Figueroa | first4 = A. | last5 = Llombart-Bosch | first5 = A. | title = CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. | journal = Am J Clin Pathol | volume = 117 | issue = 1 | pages = 126-31 | month = Jan | year = 2002 | doi = 10.1309/2EXB-70CW-3U6P-VQ6H | PMID = 11789717 }}</ref>).
*[[Atypical fibroxanthoma]] (19 of 26 cases<ref name=pmid11789717>).

==See also==
*[[Immunohistochemistry]].

==References==
{{Reflist|1}}

[[Category:Immunohistochemistry]]